The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of ethnicity with overall survival in patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma
 
Karun Neupane
No Relationships to Disclose
 
Riyasha Dahal
No Relationships to Disclose
 
Abdul-Hamid Bazarbachi
No Relationships to Disclose
 
Daniel Klein Reef
No Relationships to Disclose
 
Rama Al Hamed
No Relationships to Disclose
 
Kith Pradhan
No Relationships to Disclose
 
Kira Gritsman
No Relationships to Disclose
 
Eric J. Feldman
No Relationships to Disclose
 
Mendel Goldfinger
No Relationships to Disclose
 
Noah Kornblum
No Relationships to Disclose
 
Aditi Shastri
Honoraria - National Association of Continuing Education (NACE); Peerview
Consulting or Advisory Role - Gilead Sciences; Kymera; Rigel
Research Funding - Kymera
 
Yang Shi
No Relationships to Disclose
 
Yanhua Wang
No Relationships to Disclose
 
Ioannis Mantzaris
No Relationships to Disclose
 
Nishi Shah
No Relationships to Disclose
 
Dennis Cooper
No Relationships to Disclose
 
Amit Verma
Stock and Other Ownership Interests - Stelexis Therapeutics; ThromboGenics
Honoraria - Acceleron Pharma; Celgene; Stelexis Therapeutics
Consulting or Advisory Role - Janssen; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Marina Konopleva
Honoraria - Abbvie; Amgen; Amgen; Forty Seven; Genentech; KisoJi Biotechnology; Roche; Stemline Therapeutics
Consulting or Advisory Role - AbbVie; Amgen; Forty Seven; Genentech/Roche; Janssen; KisoJi Biotechnology; KisoJi Biotechnology; Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Agios (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Forty Seven (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Eli LIlly- Research Funding; Issued/ Licensed; Novartis- PENDING; Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities); Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities)
 
R. Alejandro Sica
Consulting or Advisory Role - Morphosys